S2 Solution
NDC Package 0487-5901-99
Package Information
S2 (racepinephrine hydrochloride) solution is the ingredient is used in an aqueous solution at a concentration equivalent to 1 percent epinephrine.Do not use more than directedFor use in a hand-held rubber bulb nebulizer: Add 0.5 ml (contents of one vial) of solution to nebulizer. This formulation utilizes a solution delivery system. Marketed by Nephron Pharmaceuticals Corporation, this product is identified by NDC 0487-5901 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 310133 - racepinephrine 2.25 % Inhalation Solution
- RxCUI: 310133 - racepinephrine 22.5 MG/ML Inhalation Solution
- RxCUI: 310133 - racepinephrine 11.25 MG per 0.5 ML Inhalation Solution
- RxCUI: 863968 - S-2, 2.25 % Inhalation Solution
- RxCUI: 863968 - racepinephrine 22.5 MG/ML Inhalation Solution [S-2]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0487 - Nephron Pharmaceuticals Corporation
- 0487-5901 - S2
- 0487-5901-99 - 30 POUCH in 1 CARTON / 1 VIAL, SINGLE-USE in 1 POUCH / .5 mL in 1 VIAL, SINGLE-USE
- 0487-5901 - S2
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0487-5901-99 identifies a specific commercial package of 30 pouch in 1 carton / 1 vial, single-use in 1 pouch / .5 ml in 1 vial, single-use of S2, a human over the counter drug labeled by Nephron Pharmaceuticals Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This solution is formulated for respiratory (inhalation) use and contains racepinephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nephron Pharmaceuticals Corporation on January 01, 2000. The current certification is valid through December 31, 2027.
How is this Nephron Pharmaceuticals Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00487590199. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.